These topics were tagged with "Pharma industry"
-
16/05/2013 - Pharma must provide convincing evidence of drug value
The pharmaceutical industry has now entered the Outcomes Era where compounds must supply convincing evidence of a new drug’s value, with proof of the best possible health outcomes and additio... -
16/05/2013 - The Ranbaxy whistleblower and the scheme to fool the FDA
Earlier this week, the feds finally reached closure with Ranbaxy Laboratories with a $500 million deal to settle criminal and civil charges for a serious and widespread manufacturing ruse. The gene... -
10/05/2013 - Analysis: Drugmakers face more scrutiny of discordant U.S. prices
The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and AstraZeneca ha... -
04/05/2013 - Gilead Sciences reports higher sales, FDA letter
Sales rose more than 8% as Gilead's newest HIV drugs gained traction Profits grew 63% from a year earlier, helped by lower acquisition costs Gilead got an FDA letter related to laborato... -
02/05/2013 - Ascletis gains China market rights from Janssen to a clinical stage HIV protease inhibitor
TMC310911 is third product in growing Ascletis pipeline of infectious disease and cancer therapeutics Hangzhou, China and Research Triangle Park, NC (April 30, 2013) – Ascletis today ann... -
02/05/2013 - Vertex Pharmaceuticals swings to 1st-quarter loss on write-down
Vertex Pharmaceuticals Inc. (VRTX) swung to a first-quarter loss on a write-down tied to its hepatitis C program, as sales of Incivek also slid. The pharmaceutical company has now reported four... -
24/04/2013 - Global pharma to return to growth this year, says Moody's
The outlook for the global pharmaceutical industry will remain stable over the next 12-18 months, reflecting the expectation of the sector returning to earnings growth this year, says rating agency... -
23/04/2013 - Biotechs poor at showing pipeline value to payers: E&Y
The annual biotechnology report from Ernst & Young claims that the major players continue to perform well but claims that in a challenging environment, the rest of the sector needs to up ... -
22/04/2013 - Report heralds rise of China in life sciences
A new report on the life sciences sector rom intellectual property specialists Marks & Clerk claims that while the USA and China top the list for market attractiveness, Europe is coming "a... -
19/04/2013 - Big Biotech growth “outpacing Big Pharma”
As healthcare shifts to a new value-based focus, Big Biotech companies are demonstrating that they are better positioned than their pharmaceutical industry counterparts to meet changing demands, sa... -
10/04/2013 - EATG Position Paper on the Clinical Trials Regulation proposed by the European Commission
EATG has adopted a Position Paper on the EU Clinical Trials Regulation, which is under discussion within the Council of the EU and European Parliament following the European Commission’s prop... -
09/04/2013 - The pharma reputation in the US and UK is... not so good
Earlier this year, a survey of 600 patient groups around the world found that the overall reputation of the pharmaceutical industry - or more specifically, 29 large drugmakers - had taken... -
06/04/2013 - The judgment in Novartis v. India: What the Supreme Court of India said
As part of a series of amendments to the India Patents Act that took effect on January 1, 2005, the Parliament of India adopted Section 3(d). This statutory provision has been in force for more tha... -
06/04/2013 - Debunking pharma's cant against the Novartis judgment: myth and fact
Novartis, its fellow Big Pharma multinationals, Chambers of Commerce, and PhRMA have all roundly denounced India's Supreme Court's decision invalidating Novartis' patent application for... -
03/04/2013 - Australian Pharmaceutical Patents Review draft report critical of patent extensions, R&D funding
The Australian Pharmaceutical Patents Review yesterday issued its draft report, recommending that the Australian government reduce pharmaceutical patent extension terms and use estimated savin... -
03/04/2013 - DFH Pharma, USA partners with Hetero Group, India to develop 2nd generation HIV maturation inhibitor drugs
GAITHERSBURG, Md., April 3, 2013 /PRNewswire-iReach/ -- DFH Pharma, Inc. ("DFH"), a privately held pharmaceutical company focused on the development of HIV therapeutics, announced that it... -
02/04/2013 - Analysis: Big Pharma down, not out, after Indian patent blow
Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world's eighth largest market... -
02/04/2013 - India’s drug patent rejection shows emerging markets not lucrative, could bring cutbacks there
The India Supreme Court’s rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world’s largest drugmakers. The ru... -
29/03/2013 - African leaders call for greater industrialization of an emerging Africa
African Ministers of Finance and other leaders have agreed that the continent needs to shift from a reliance on exports of primary commodities to greater industrialization in order to accelerate th... -
29/03/2013 - Pharma needs to redefine emerging markets: Booz study
Pharmaceutical companies that thought of the emerging markets as a solution to their woes in Europe and the USA need to tailor their operations to each individual country. That is one of the co... -
25/03/2013 - Theratechnologies: Health Canada decision appealed
Read the press release here. ... -
20/03/2013 - French drugs market to shrink further in 2013: study
Drug sales will shrink further in France this year as government austerity measures curb healthcare spending in Europe's second-biggest drugs market, a study said on Tuesday. The study publ... -
15/03/2013 - GlaxoSmithKline boss says new drugs can be cheaper
The pharmaceutical industry should be able to charge less for new drugs in future by passing on efficiencies in research and development to its customers, according to the chief executive of GlaxoS... -
13/03/2013 - Pharma and Interpol team up to tackle fake meds
Interpol and 29 of the world’s largest pharmaceutical companies have launched another initiative to combat the spread of counterfeit drugs. The three-year deal will see the drugmakers put... -
12/03/2013 - US pharma firm seeks to stop EU agency releasing drug data
The European Medicines Agency, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny, a move that is creating tensions with drugmakers worri... -
12/03/2013 - Greek firms blame govt as drug access
The provision of pharmaceutical care in Greece is now at breaking point, and the blame lies with the Health Ministry, according to the national pharmaceutical industry association. The Hellenic... -
12/03/2013 - US pharma: 907 biologic drugs and vaccines now in R&D
US biopharmaceutical companies are using biological processes to develop 907 drugs and vaccines targeting more than 100 diseases, according to new industry data. The report, from the Pharmaceut... -
07/03/2013 - Roche data transparency plans are “all talk and no action”
Roche’s plans to expand third-party access to its clinical-trial data have attracted further heavy criticism from the research community. The latest broadside comes in a letter to the BMJ... -
05/03/2013 - Sub-Saharan anti-infective drugs market “set for fast growth"
The markets for anti-infective drugs in Malawi, Mauritius and Zimbabwe are set to increase from combined a value of US$186.2 million in 2011 to $377.2 million in 2018, according to new forecasts. ... -
04/03/2013 - Pharma's "7 billion-euro Eurozone price cuts"
Pharmaceutical companies have slashed their prices to Eurozone countries by a total of around seven billion euros, but the resulting parallel trade means there are now serious shortages of medicine...
News
You can also search the entire site for "Pharma industry" by clicking here